Skip to main content

Table 2 Analysis the HSP70 protein expression levels in early stage LSCC and than in late stage LSCC

From: HSP70: a promising target for laryngeal carcinoma radiaotherapy by inhibiting cleavage and degradation of nucleolin

   HSP70 expression levels  
Clinicopathological parameter n 0 1+ 2+ 3+ P
stage I - II 21 2 6 10 3  
stage III - IV 29 0 1 19 9 0.015